DBV Technologies S.A. — Investor Relations & Filings
DBV Technologies is a clinical-stage company focused on developing treatments for food allergies. Its core technology is the proprietary Viaskin patch, an investigational platform for epicutaneous immunotherapy (EPIT). This technology is designed to administer allergens to intact skin, aiming to re-educate the immune system and induce tolerance without significant transfer of the antigen into the bloodstream. The company's lead product candidate, Viaskin Peanut (DBV712), is in late-stage clinical development for the treatment of peanut allergy. The development pipeline also includes Viaskin Milk (DBV135) for milk allergies, which has completed early-stage clinical studies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-11 | English | |
| DEF 14A - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-11 | English | |
| 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-05 | English | |
| S-8 - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-04 | English | |
| 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-04-30 | English | |
| 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-03-26 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Lyra Therapeutics, Inc.
Clinical-stage biotech developing sinonasal implants to tre…
|
LYRA | US | Manufacturing |
|
Lytix Biopharma AS
Clinical-stage immuno-oncology company developing oncolytic…
|
LYTIX | NO | Manufacturing |
|
Mabion S.A.
A CDMO providing end-to-end services for protein-based biot…
|
MAB | PL | Manufacturing |
|
Mabpharm Limited
Developing and commercializing monoclonal antibody drugs fo…
|
2181 | HK | Manufacturing |
|
MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
Biopharmaceutical firm developing therapeutic antibodies an…
|
688062 | CN | Manufacturing |
|
Maccura Biotechnology Co.,Ltd
Provides in vitro diagnostic products, automated analyzers,…
|
300463 | CN | Manufacturing |
|
MACROGENICS INC
A biopharmaceutical company developing antibody-based thera…
|
MGNX | US | Manufacturing |
|
Macter International Limited
A prominent pharma company with 40+ years experience in man…
|
MACTER | PK | Manufacturing |
|
MADRIGAL PHARMACEUTICALS, INC.
Biopharmaceutical company with the first FDA-approved treat…
|
MDGL | US | Manufacturing |
|
Magle Chemoswed Holding AB
A CDMO serving the pharma and medical device industries fro…
|
MAGLE | SE | Manufacturing |
DBV Technologies S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33512/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33512 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33512 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33512 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33512}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DBV Technologies S.A. (id: 33512)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.